Literature DB >> 6381473

Use of naltrexone to extinguish opioid-conditioned responses.

C P O'Brien, A R Childress, A T McLellan, J Ternes, R N Ehrman.   

Abstract

Opioid use generates many conditioned responses associated with the sights, sounds, smells, and rituals experienced during addiction. Environmental stimuli alone can provoke withdrawal symptoms and contribute to relapses in treated patients. The use of naltrexone in a program designed to progressively extinguish conditioned drug responses is described. Since naltrexone effectively blocks opiate effects at the receptor level, heroin injections produce no euphoria. Unreinforced self-injections diminish the responses learned during the period of drug abuse and protect the patient from rapid readdiction. Patients are confronted with a hierarchical set of drug-related stimuli and taught a muscular relaxation procedure to relieve arousal and discomfort. The continued administration of naltrexone, the self-induced relaxation response, and the repeated presentation of drug-related stimuli result in the eventual diminution or extinction of the arousal properties of the imagery and environmental stimuli associated with addiction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381473

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

1.  The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters.

Authors:  Hannah K Knudsen; Lori J Ducharme; Paul M Roman
Journal:  Drug Alcohol Depend       Date:  2006-09-12       Impact factor: 4.492

2.  Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction.

Authors:  Karyn M Myers; William A Carlezon
Journal:  Neurosci Biobehav Rev       Date:  2010-01-28       Impact factor: 8.989

3.  Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism.

Authors:  Edward V Nunes; Adam Bisaga; Evgeny Krupitsky; Narinder Nangia; Bernard L Silverman; Sarah C Akerman; Maria A Sullivan
Journal:  Addiction       Date:  2019-08-04       Impact factor: 6.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.